ResearcherInje UniversityActive in the last 2 years

Fen Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3143-9265; OpenAlex author ID A5101410155. Sources: OpenAlex.

Their work

Papers: 3 (first author 2, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 3

Preclinical evaluation of uPAR-ICG-FVIOs for dual-mode imaging and magnetic hyperthermia therapy in pancreatic cancer. Last author DOI 10.3389/fphar.2025.1681718 ↗
PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer First author DOI 10.3389/fphar.2022.890614 ↗
PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway. First author DOI 10.3390/ijms231911414 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sang Seok Koh · 2 shared papers, 2022 · strength 0.34
- Paper PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway. DOI 10.3390/ijms231911414 ↗
- Paper PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer DOI 10.3389/fphar.2022.890614 ↗
Tao Luo · 1 shared paper, 2025 · strength 0.28
- Paper Preclinical evaluation of uPAR-ICG-FVIOs for dual-mode imaging and magnetic hyperthermia therapy in pancreatic cancer. DOI 10.3389/fphar.2025.1681718 ↗
So Eun Youn · 1 shared paper, 2022 · strength 0.17
- Paper PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway. DOI 10.3390/ijms231911414 ↗
Tae Heung Kang · 1 shared paper, 2022 · strength 0.17
- Paper PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway. DOI 10.3390/ijms231911414 ↗
Seung‐Mo Hong · 1 shared paper, 2022 · strength 0.16
- Paper PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer DOI 10.3389/fphar.2022.890614 ↗
Yeon‐Jeong Kim · 1 shared paper, 2022 · strength 0.16
- Paper PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer DOI 10.3389/fphar.2022.890614 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.